Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). [Phase 4]

View source ↗

Summary

Phase 4 trial exploring the efficacy and safety of pirotinib (pyrotinib) plus trastuzumab and taxanes in trastuzumab-treated HER2-positive advanced breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyrotinib (pyrotinib)
  • Trastuzumab (trastuzumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: HER2-positive Breast Cancer, Advanced Breast Cancer | Phase 4 | Status: RECRUITING